Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check6 days agoChange DetectedExpanded Access record added and availability noted outside the clinical trial; new locations Calgary, Canada and Roma, Italy are listed with updated address formatting, and the revision version updated to v3.5.2 (replacing the prior v3.5.0 entries).SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.5.0 and no longer displays Revision: v3.4.3.SummaryDifference0.0%

- Check42 days agoChange DetectedThe trial site list was updated to add Texas Children's Cancer and Hematology Center in Houston and a Calgary, Canada site (T3B6A8), and to remove the prior Calgary entry.SummaryDifference0.3%

- Check50 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this change does not affect study content, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedFooter now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.